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Abstract
The American Academy of Pediatrics has begun an initiative called Accelerating
Improved Care for Children with Asthma Program Chapter Quality Network Asthma
Project, Phase 3 (CQN3). This project is a conscious effort to enhance the quality of life
in asthmatics. One important initiative included in this project is to achieve 90% or
greater influenza vaccination rates in children age six months and older with asthma.
This is because children with asthma who contract influenza have increased morbidity
and mortality rates than do their non-asthmatic counterparts. Studies have shown
vaccination rates for these children are typically between 9 to 26%, and vaccination is the
best and safest way to prevent influenza.
The purpose of this study was to evaluate the effectiveness of an evidenced-based
intervention bundle on the influenza vaccination rates among asthmatic children age six
month to 18 years in one local pediatric office.
Data was collected through a retrospective chart review looking at vaccination
rates for the (September to March) 2012-2013 influenza season and the 2013-2014
influenza season to see if an evidenced-based intervention bundle could make a
difference in vaccination compliance.
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Chapter 1: Introduction and Literature Review
Children with asthma ages six-months to eighteen years are being under
vaccinated against the influenza virus. This is of concern because children who have
chronic illnesses, such as asthma, are at an increased risk for developing serious
complications from influenza (Bhat et al., 2005; Erhart, Rangel, Lu, & Singleton, 2004;
Neuzil, Wright, Mitchel, & Griffin, 2000). Influenza is attributable to more illness each
year than any other illness that is preventable by a vaccine (Monto, 2002). The Centers
for Disease Control and Prevention (CDC) estimates that approximately 100 children die
each year from influenza and its complications (Fiore et al., 2008). Children with asthma
who contract influenza are at a considerably higher risk for severe adverse complications
than are children without asthma. These children have an increased mortality and
morbidity, have more school absences, are at higher risk for developing pneumonia,
require twice as many antibiotic therapies, and are more likely to visit a physician or
other healthcare provider than are children without asthma (Glezen, 2000; Izurieta et al.,
2000; Menec, Black, MacWilliam, & Aoki, 2003; Neuzil et al., 2000; O'Brien et al.,
2004). These influenza related risks are of equal concern to every asthmatic child
regardless of severity of disease (Robertson, Rubinfeld, & Bowes, 1992). This means
that a child with mild asthma is equally at risk for developing serious influenza related
complications, as is a child with severe asthma. It is also important to understand that
research has shown that children with asthma are not more susceptible for getting
influenza, they are simply at a higher risk for developing serious complications from the
1
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flu, and this is why children with asthma should receive the flu vaccine (Centers for
Disease Control and Prevention (CDC) seasonal influenza (flu) - information for people
with asthma, 2013).	
  
Asthma is the most common chronic disease in childhood. It currently affects an
estimated 7.1 million children under 18 years (American Lung Association (ALA), 2012;
Neuzil et al., 2000). A similar report by the National Heart, Lung, and Blood Institute
Expert Panel Report 3 (2007), states asthma affects over 6 million children under the age
of 18 in the United States, and places an extreme burden on the patient, families, and
society. In 2008, asthma alone accounted for 10.5 million school absentees and cost the
child’s caretakers $726.1 million per year because of missed work related to the school
absences (Akinbami, Moorman, & Liu, 2011; Sharma, 2013).
Asthma is a chronic inflammatory disease of the lung airways in which
inflammation causes the airways to become swollen. It is a complex disorder that
involves airflow obstruction, bronchial hyper-responsiveness and an underlying
inflammatory response resulting in coughing, wheezing, shortness of breath, and chest
tightness. These symptoms can be persistent or episodic. Despite not fully
understanding the exact pathophysiology behind the inflammatory processes involved
with asthma, research has implicated several factors that can trigger this inflammatory
response. These factors have been identified as environmental factors such as tobacco
smoke, airborne allergens, viral respiratory infections, cold air, and physical activity
(Expert panel report 3 (EPR-3): Guidelines for the diagnosis and management of asthma
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summary report 2007. 2007; CDC- seasonal influenza (flu)- information for people with
asthma, 2013; Akinbami et al., 2011).
Studies have shown that upper respiratory tract infections are the main triggers for
acute asthma exacerbation, accounting for up to 80% of the exacerbations in asthmatic
children, and influenza accounts for a significant number of these respiratory infections.
“The influenza-attributable burden is substantially greater among children with asthma
than among healthy children” (Miller et al., 2008, p. 7). In fact, Miller et al., 2008 found
there to be a 50-fold higher inpatient hospital burden for children with asthma than
among healthy children.
Influenza, commonly known as the flu, is a contagious seasonal respiratory illness
caused by influenza A or B viruses that occur in outbreaks each year during the winter
months (Fiore et al., 2009; Maltezou, 2008; Neuzil et al., 2000). In the United States,
influenza accounts for an average of 36,000 deaths each year from flu-related
complications, and the risk of death is greatest among children with chronic medical
conditions such as asthma (Thompson et al., 2003). The 36,000 death per year is the
most often cited number, however, the CDC believes based over a 31 year span from
1976 to 2007 the more accurate number to be between 3,000 and 49,000 deaths from
influenza each year due to the unpredictability and variability each year (CDC, 2011).
The total economic burden influenza alone place on Americans is quite
substantial. Molinari et al. (2007), estimated the burden of direct medical costs to be 10.4
billion dollars (95% confidence interval [CI], 4.1 to 22.2 billion dollars) and found there
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to be lost earnings of around 16.3 billion dollars (95% CI, 8.7 to 31.0 billion dollars) per
year. When they added indirect costs this number inflated to 87.1 billion dollars (95%
CI, 47.2 to 149.5 billion dollars) per year.
Considering the impact and burden that asthma and influenza present individually
it is easy to see how the burden and health risk can be confounded when someone with
asthma, especially a child with asthma, contracts the influenza virus. The risks and
burden grow exponentially.
A report released by the CDC on March 22, 2013 reported that during the 20122013 flu season 105 children have died from the flu (CDC- influenza-associated pediatric
mortality, 2013). Of the 105 children that died from influenza, 90 percent had not
received the flu vaccine, and 60% of these unvaccinated children were from the high-risk
group, with asthma being the most prevalent high-risk disease from this group (CDCseasonal influenza (flu)- CDC reports about 90 percent of children who died from flu this
season not vaccinated, 2013).
In a similar CDC report released January 17, 2014 they reported that of the 20
pediatric deaths that week only one child was fully vaccinated against influenza. In this
report they again state that the single best way to protect children from the influenza virus
is to have them vaccinated (CDC- flu season continues; severity indicators rise | news and
spotlights | influenza (flu), 2014).
Despite this understanding, knowledge, and support for vaccination by the
American Academy of Pediatrics, and the Advisory Committee on Immunization, which
advises the CDC, vaccination rates among children with chronic, high-risk conditions
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including asthma have traditionally remained low ranging from 9% to 26% (M. F. Daley
et al., 2004; M. F. Daley et al., 2005; Kramarz et al., 2000). Considering the increased
risk influenza presents to this population it is easy to see why increasing vaccination in
this population should become a focal point for the healthcare provider.
Other studies have reported higher rates, up to 56%, in practice settings utilizing
reminder/recall systems or year round scheduling of influenza vaccination in an attempt
to increase vaccination rates among this high-risk population (Dombkowski, Harrington,
Dong, & Clark, 2012; Esposito et al., 2009; Paul et al., 2006; Gaglani, Riggs,
Kamenicky, & Glezen, 2001). These studies have begun to investigate ways to increase
vaccination rates among asthmatic children, and improved rates are being seen in these
practice settings. Additionally, these studies report how poor vaccination rates and steps
needed to improve these rates are a multifactorial problem that will not easily be solved.
They report further studies are needed, specifically directed at establishing evidenced–
based directives and procedures for increasing vaccination rates.
In addition to the need for creation of evidenced-based multidimensional
approaches to solving this problem, Fiore et al. (2010) reported that the strongest
predictor and reason for vaccination compliance comes from healthcare provider
recommendation. This is why every healthcare provider needs to encourage influenza
vaccination, unless contraindicated, with particular emphasis on high-risk populations
such as asthmatic children. Daley et al. (2005) reported that over 80% of pediatric
asthma related-visits throughout the course of a year amount to missed opportunities for
the healthcare provider to educate and encourage vaccination against influenza, and how
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the primary care provider must be more diligent in incorporating vaccination discussions
into more visits during the course of the year, not just during flu season. Similarly, Chen
et al. (2011) discussed the importance of and the need for primary care providers to
develop strategies to increase influenza vaccination rates among children with asthma.
Review of Literature
The literature review, for this study, has been extended beyond ten years to take
into account a historical perspective on this issue. In reviewing the literature, multiple
factors have been studied and discussed as it relates to vaccination rates in the United
States and have found to include: the media, healthcare provider beliefs and
recommendations, parental beliefs, epidemic factors, and systems factors. These factors
have been found to both encourage and/or deter a person from receiving the influenza
vaccination (Yoo, 2011). Each individual factor presents an avenue for future research
for the development of a multidimensional approach for increasing vaccination rates that
is both generalizable and applicable to everyone.
Studies have been contradictory as to the safety, efficacy, and whether influenza
vaccination can lead to reductions in asthma exacerbations. Several retrospective studies
have shown reductions in asthma exacerbations, reductions in the number of lower
respiratory infections, and decreased use of oral steroids in children with asthma who
were vaccinated against influenza (Kramarz et al., 2001; Ong, Forester, & Fallot, 2009;
Smits, A, J et al., 2002). While other studies have reported contradictory findings.
Several randomized, double blind, placebo-controlled studies have failed to demonstrate
this decrease in asthma exacerbations in asthmatic children after receiving the influenza
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vaccination (Abadolu, Mungan, Paaoglu, Çelík, & Misirligil, 2005; Bueving et al., 2004;
Christy, Aligne, Auinger, Pulcino, & Weitzman, 2004).
Reports of influenza vaccination being harmful to asthmatic children have been
published in the past as well (Campbell & Edwards, 1984; De, Degenhart, Neijens, & al,
1984). These reports had small sample sizes and were mostly subjective, however this
idea remains imbedded in the minds of Americans. In newer double blind, placebocontrolled studies the results indicate that the vaccine is safe for asthmatic children, and
does not lead to increased asthma exacerbations in the weeks after receiving the influenza
vaccine as compared to placebo injection (ALA, 2001; C. J. Cates, Jefferson, & Rowe,
2008; Tata et al., 2003).
In a systematic Cochrane review by Cates & Rowe (2013) to assess the safety and
effectiveness of the influenza vaccine in patients with asthma concluded that evidence
from randomized clinical trials has failed to show a decrease in the number of asthma
exacerbations after receiving the influenza vaccine, but did report an increase in quality
of life scores among children with confirmed influenza. This report also concluded that
the influenza vaccine is safe for children with asthma.
Limitations for any study looking at these factors are exacerbated by the
fluctuating virility and activity each influenza season presents, in addition the overall
effectiveness of the vaccination each season comes into question. These factors can lead
to skewed data when studies like these are performed over one or two influenza seasons.
The need for larger studies, which include multiple locations spread over several
influenza seasons, will provide increased reliability and generalizability of findings.
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Support for the influenza vaccination comes directly from the historical success of
the vaccine. According to Kidd, Wones, Momper, Bechtle, & Lewis (2012),“annual
vaccination is the most effective method for preventing influenza (Fiore et al., 2008;
Stewart, 2009), and vaccination is credited with preventing more death and illness over
the past 100 years than any other medical achievement” (CDC, 1999; Field, 2009 (p. 1)).
This is why, despite the conflicting and limited direct evidence in the literature that
influenza vaccines are beneficial to children with asthma, as evidenced by failure of some
research trials to demonstrate beneficial effects in preventing asthma exacerbations in
children after influenza vaccination, the CDC, National Asthma Education and
Prevention Program (NAEPP), the American Academy of Pediatrics (AAP), and various
other experts strongly recommend annual vaccine administration to children with asthma.
Their recommendations are based upon the whole of the evidence available to them and
their clinical experience and expertise. These recommendations also take into account
the potential risks and weigh them against the known benefits influenza vaccination gives
to the asthmatic child.
As this literature review shows, influenza vaccination is often occurring less than
one-third of the time in these high-risk children; universal vaccination is and will remain
a challenge that must be overcome. The described increased risk influenza presents to
children with asthma, the burden influenza presents for children with asthma, evidence
that recent efforts by healthcare providers to increase vaccination rates work, and
weighing the risks verses the benefits vaccination affords this population, is why the AAP

9
has begun an initiative called Accelerating Improved Care for Children with Asthma
Program Chapter Quality Network Asthma Project, Phase 3 (CQN3).
This initiative is a conscious effort to implement the NAEPP and National Heart,
Lung, and Blood Institute Expert Panel Report 3 (2007), asthma guidelines to help
educate healthcare providers to improve the care of children with asthma. One of the key
points in this initiative is to achieve influenza vaccination rates of 90% or better in
children six months and older with asthma. However, this initiative does not offer an
evidenced-based approach on achieving this goal. Thus, the goal of this research article
was to evaluate the effectiveness of an evidenced-based intervention bundle on the
influenza vaccination rates among asthmatic children age six-months to 18 years in one
local pediatric office.

Chapter 2: Theoretical Framework and Model
The research conducted by Minor (2013) will be the guiding influence in creating
the evidenced-based intervention bundle that will be implemented in this study. This
research “appraised, graded, summarized, and synthesized 26 articles into strong,
moderate, and weak practice guideline recommendations” (p. 16). Using these
recommendations as a practical guide, an interventional bundle was constructed, adopted,
and implemented at this local pediatric office.
The bundle includes making vaccination an obvious priority at the office,
physician recommendation for vaccination, providing education about why vaccinations
are important, why it is recommended, and debunking any misinformation or
misconceptions the parents’ or patients’ may have, and lastly implementing a reminder
system using phone call and mailed card reminders.
The local office has created a registry for its asthmatic child with the specific
intent of tracking vaccination rates, and they have signage up in their office and front
door supporting and endorsing influenza vaccination for all patients and parents to see.
They have influenza specific educational packets and booklets from the CDC and the
American Lung Association that they are utilizing and handing out to all the asthmatic
patients, and each physician is making it a priority to have a conversation about their
support for and reasons why they personally recommend the influenza vaccination.
These interventions are either strong or moderate levels of recommendation from
Minors’ (2013) systematic literature review. This research showed that education was by
far the strongest influence on improving vaccination rates. When reminder systems are
10
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utilized children are five times more likely to be vaccinated as compared to offices not
using a reminder system. Studies have also shown improved vaccination compliance
when physicians personally recommend the vaccine and when the office makes
vaccination a priority there is heightened patient/parent perception towards disease
prevention if they choose to vaccinate.
Study Design
The study is a quasi-experimental design study. The variables of interest include
1) children with asthma (six-months to 18 years of age), 2) influenza, 3) flu vaccine, and
4) subsequently examining number of those children with asthma choosing to receive the
flu vaccine. Then comparing vaccination rates from 2012-2013 flu season with the 20132014 flu season to evaluate if the implemented bundle of evidenced-based educational
interventions improved these rates. Ultimately, there is a goal for 90% vaccination rates
among these asthmatic children as set forth by the AAP asthma initiative.
Definition of terms
Asthma is defined as a common chronic disorder of the airways that involves a
complex interaction of airflow obstruction, bronchial hyper-responsiveness and an
underlying inflammatory response resulting in coughing, wheezing, shortness of breath,
and chest tightness (Expert panel report 3 (EPR-3): Guidelines for the diagnosis and
management of asthma-summary report 2007, 2007). For this study, a child with asthma
is determined by their ICD code diagnosis of asthma. Influenza is defined as a seasonal
contagious respiratory illness caused by influenza A or B viruses that occur in outbreaks
each year during the winter months (Fiore et al., 2009; Maltezou, 2008). The flu vaccine
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is defined as an injectable solution containing trivalent inactivated (killed) influenza
viruses that are given with a needle, usually in the arm to protect a person against getting
influenza. The intranasal form containing the live-attenuated influenza vaccine is only
indicated for children age two or older. This form is not indicated for children with
chronic medical conditions, such as asthma because of the increased risk of
complications the flu presents to this population and increased reports of wheezing with
this formulation (Committee on Infectious Diseases, 2012).
The evidenced based educational bundle is defined 1) as the office making
vaccination an obvious priority at the office, 2) physician recommendation for
vaccination, 3) providing education about why vaccinations are important, why it is
recommended, and debunking any misinformation or misconceptions the parents’ or
patients’ may have, and 4) implementing a reminder system using phone call and mailed
card.
The barriers are defined as the misconceptions about the safety and efficacy of the
vaccine, the idea, stemming from older literature, that the vaccine will worsen asthma in
children, the lack of education for parents of asthmatic children, and the failure of the
healthcare provider and office to make vaccination a priority.
Theoretical Framework
The framework for this project is based from the Health Belief Model. This
model was developed in the 1950s by social psychologists Hochbaum, Rosenstock, and
Kegels. This psychological model attempts to explain and predict healthy behaviors by
focusing on the attitudes and beliefs of individuals. This model was developed in
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response to failure of a free tuberculosis health-screening program (Chen et al., 2011).
The described psychological conceptual model and the theoretical model mirror each
other, in that the focus is on the physiological effects of the asthmatic child contracting
influenza, and how influenza vaccination can thwart the established increased burden and
risk for serious complications influenza possesses for asthmatic children.
The evidenced-based educational program was developed with the Health Belief
Model as the guide, and this research will be to evaluate the effectiveness of these
interventions to determine if, once implemented, they influenced compliance in the
number of asthmatic children, from this one pediatric office, who received the influenza
vaccine during the 2012-2013 season as compared to the 2013-2014 season. The
implementation of this bundle should demonstrate increased influenza vaccination
compliance for this study population. Therefore, a map was developed to explain the
psychological concept that is the basis for the recommendation of influenza vaccination.
The map is as follows:
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Child with
asthma

Decreased barriers and
increased
understanding of
benefit for vaccination

Increased
influenza
vaccination rates

Evidenced
based
education
program

This map shows the psychological idea that with the implementation of an
evidenced-based educational program barriers and misunderstanding will be decreased
resulting in increased influenza vaccination rates. This model defines the population at
risk, and shows that an intervention will occur to help reduce the barriers for vaccination
and increase the understanding of the benefits of vaccination in children with asthma.
The evidenced-based program will identify and reduce the barriers, provide information,
provide awareness, and provide guidance in why it is important to vaccinate children with
asthma against the flu virus. These are all key elements of the health belief model.

Chapter 3: Methodology
Subjects
A retrospective chart review was completed to determine the number and
percentage of children with asthma who receive the influenza vaccine during the
September 2012-March 2013 and September 2013-March 2014 flu seasons. The data for
the project will come from a local pediatrician office in Xenia, Ohio. This is the only
pediatric office located in this city of 25,000 residents. This practice is estimated to have
approximately 5000 patients. Approximately 60% are self-pay or have private insurance,
and either Medicare or Medicaid covers the remaining 40% of the patients. The practice
employs two pediatricians and they have a supportive nursing and administrative staff
available to care for these patients. This practice is committed to serving the children of
this area, but more specifically they are committed to improving vaccination rates among
the asthmatic children in their care.
The convenience sample will be obtained by utilizing the office billing system
looking for asthma ICD codes, pulling these patients charts, and then obtaining
information as to whether they received the influenza vaccine or not. The office has also
established an asthma/influenza registry, which was also utilized in obtaining this needed
information. Additionally, the Ohio Statewide Immunization Information System (SIIS)
was used to assure a comprehensive review of vaccination compliance among these
children. The SIIS was utilized to ascertain children not vaccinated at this office to again
ensure a more comprehensive review of vaccinated individuals. From this information
the number and percentage of asthmatic children who received the influenza
15
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vaccine was determined. Using the historical data gathered by Minor, 2013 and the data
gathered by this researcher the two influenza seasons at this one pediatric office was then
be compared and contrasted.
Inclusion criteria comprised children age six-months to eighteen years of age
belonging to this pediatric practice with an asthma diagnosis determined by ICD codes
493.00, 493.01, 493.02, 493.10, 493.11, 493.12, 493.20, 493.21, 493.22, 493.80, 493.81,
493.82, 493.90, 493.91, and 493.92. The immunization status had to been known for the
patient to be included in the study. Children with confirmed allergies to eggs were
excluded. Individual billing numbers were used as the patient identifier in an attempt to
avoid duplication and to assure patient confidentiality and anonymity. These billing
numbers were destroyed after the data collection was completed to further minimize any
potential risk.
Ethical considerations
Cedarville University’s Institutional Review Board reviewed the proposal for this
research and approved the ethical considerations of this thesis on February 19, 2014. The
data was then obtained from the local pediatric office. Absolute care was taken to ensure
the anonymity, privacy, and safety of the subjects was preserved during the data
collection and subsequent statistical analyses and results review.
Design
Weaknesses of this research include the use of a retrospective quasi-experimental
study design that is simple observation and data collection. This researcher also had no
control over the actual delivery of the evidenced-based interventional bundle.
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The interventions were established and adopted by the physicians of this pediatric office
from the recommendations made by Minor, (2013). Another weakness is the fact that
this research used convenience sampling without randomization.
This design allowed for some examination into possible associations between the
variables, and helped establish if the evidenced-based education bundle improved
influenza vaccination rates in this population of study. Also, these findings may not be
generalizable to the population as a whole, but do give some insight into the success of
this evidenced-based intervention. This is because the design included a specific subset
of the pediatric population and was limited to two influenza seasons; both may affect the
generalizability of the study, but still gives some insight into the population of interest.
Another limitation of this study came from the theoretical model guiding the
studies conception. Like all theoretical models each has its own limitations, and the
Health Belief Model is not beyond this certainty. The Health Belief Model does not
allow for a decision-making process in the model and because of this the model itself has
limitations (Keenan, Campbell, & Evans, 2007). Issues such as the one examined in this
study are complex and have personal multifactorial issues involved in each individual's
decision as it relates to their healthcare choices.
The strengths of this design stems from the practicality involved in the
employment of convenience sampling method. The design was constructed in a manner
that allowed this researcher to acquire the specific data needed to for the study. This
design allowed for an adequate sample size for the study, and time constraints were
limited since this design required data collection from existing records. The researcher
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was able to obtain the needed data relatively quickly, and this type of design is
inexpensive to complete. The sample and setting were correct and adequately met the
purpose, design, and data needs for the study. The study design creates limited ethical
considerations for the subjects involved since this is not a true experimental design, in
that there is no direct intervention on part of the researcher, no control group, thus
resulting in little if any risk of harm to the subjects.
The research was conducted at a practice open and receptive to implementing the
education bundle with the goal of achieving higher vaccination compliance rates. This
study was completed at a single practice setting thus minimized organizational factors
that may have existed between practices. These factors could potentially have accounted
for and affected the findings.
Measurement tools
This research did not utilize any special measurement tools as it pertains to the
studies data collection or analysis. The data gathered on the children with the diagnosis
of asthma included: medical record number, influenza immunization status, age, gender,
and type of insurance. The data was collected and entered into the PSPP program as
numerical values that were stored online and encrypted, and then descriptive and
correlational statistics were performed to determine if the implementation of the
evidence-based education bundle made a statistically significant difference in influenza
vaccination rates among these children with asthma.
Data Analysis
The data analysis for this study is specifically to determine if there was a
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statistically significant change in the number of children with asthma who receive the flu
vaccine during the 2012-2013 flu season verses the number of children with asthma
receiving the flu vaccine during the 2013-2014 flu season at one particular pediatrician
office in Xenia, Ohio after implementing the evidenced-based educational bundle for one
year.
An analysis was performed to see if the evidenced-based bundle influenced and
altered a difference in the number of children who received the vaccine pre-education
(2012-2013 influenza season) to the number of children who receive the vaccine post
education (2013-2014 influenza season). This researcher tested whether there were
differences between the two groups (2012-2013 flu season vs. 2013-2014 flu season).
This was ascertained by performing Chi-Squared statistical analyses on the described
data. Then looked at the vaccination rates to determine if these rates improved,
worsened, or remained unchanged with the implementation of the evidenced-based
recommendations when comparing the two respective influenza seasons. Additional
demographic data such as specific age, gender, and type of insurance was collected in this
research study to see if significant differences were present among these variables.

Chapter 4: Results
2012-2013
A retrospective chart review completed by Minor (2013), showed a total of 315
patient charts meeting the inclusion criteria for the study for the 2012-2013 influenza
season. From the 315 patients, 312 charts were retrievable and reviewed. The findings
(Table 1) showed those vaccinated to be at 42% (n= 129), while 58% (n= 183) did not
receive an influenza vaccination. The population demographics were as follows: age
ranged between 6 months to 18 years, 55% male (n= 171) and 45% female (n= 140), 69%
Medicaid (n= 215), 31% private insurance (n= 96), and one patient was identified as selfpay. In regards to statistical analyses discussed in this research the statistical significance
was set at (p< .05). Chi-squared analysis revealed a statistically significant correlation
between the type of insurance and vaccination (p= .01). Children with Medicaid were
vaccinated at a rate of 36 percent (n= 78) while their private insurance counterparts were
vaccinated at a rate of 53 percent (n= 51). Minor (2013) found no other significant
correlations.
2013-2014
A retrospective chart review was conducted for the 2013-2014 influenza season in
adherence with the previously discussed methods. A total of 625 patient charts met the
inclusion criteria for the study. All 625 charts were retrievable and reviewed. No charts
were excluded based on exclusion criteria. The result of this chart review (Table 2)
showed that while many children did receive the influenza vaccination 42% (n= 262), the
20
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majority 58% (n= 363) of these patients were unvaccinated against influenza. The
population revealed it was marginally male dominated at 56% (n= 348) as compared to
44% females (n= 277). Medicaid once again was the principal type of insurance at 62%
(n= 386) as compared to private insurance at 38% (n= 239).
While Minor (2013) revealed a statistically significant correlation between the
type of insurance and vaccination status this researcher found no correlation present. A
Chi-squared analysis was completed for the 2013-2014 influenza season data and the
analysis demonstrated no statistically significant differences in immunization rates
amongst this sample population, including insurance type and vaccination status. This
researcher found that Medicaid patients were vaccinated at a rate of 44% (n= 171) while
the private insurance patients were vaccinated at a rate of 38% (n= 91).
2012-2013 vs. 2013-2014
Correlational statistics were then run comparing the two respective influenza
seasons. The Chi-squared analysis demonstrated no statistical improvement in the overall
vaccination rates between the two respective seasons (p= .87). However, Chi-square
analysis between the two years specifically looking at the demographic subsets
demonstrated statistically significant correlations between some of the variables (Table
3).
Looking at the total population differences regarding type of insurance coverage
the analysis revealed statistically significant differences to exist (p= .03). During the
2012-2013 season Medicaid patients made up 69% (n= 215) while the 2013-2014 season
Medicaid patients made up 62% (n= 386), and the number of children with private
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insurance changed from 2012-2013 season which revealed 31% (n=96) to 38% (n=239)
during the 2013-2014 season.
Comparing specifically the Medicaid patient vaccination status during these two
seasons the analysis revealed (p= .05) a statistically significant correlation. The 20122013 Medicaid patients were vaccinated at 36% (n= 78), and those not vaccinated were at
64% (n= 137). Compared to the 2013-2014 season that showed Medicaid patients were
vaccinated at a rate of 44% (n= 171), and those not vaccinated were at 56% (n= 215).
The private insurance patients also revealed statistically significant correlation
(p= .01) between these two seasons. The 2012-2013 private insurance patients were
vaccinated at 53% (n= 51), and those not vaccinated were at 47% (n= 45). Compared to
the 2013-2014 season that showed private insurance patients were vaccinated at a rate of
38% (n= 91), and those not vaccinated were at 62% (n= 148).
Additional significant findings were found as it related to the overall pediatric
population at this office, and insurance coverage. As noted, this office has approximately
5000 patients, of which, 40% are Medicaid patients while the remaining 60% are either
private insurance or self-pay patients. When looking specifically at the asthma
population these change significantly. During the 2012-2013 season, of the 312 patients
Medicaid made up 69% while private insurance or self-pay made up 31%. This is a
significant shift in insurance coverage of the population of interest (p= .0001). During
the 2013-2014 season, of the 625 patients Medicaid made up 62% of the population while
private insurance or self-pay made up 38%. This is also represents a significant shift in
the insurance coverage for the population of interest (p= .002).
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Table 1
Population Demographics 2012-2013 season
Number
2012-2013

Percent
2012-2013

Ages
Preschool (0-5 years)
School-Aged (6-12 years)
Adolescent (13-18 years)

111
132
69

36%
42%
22%

Gender
Male
Female

171
140

55%
45%

Insurance
Medicaid
Private Insurance
Self Pay

215
96
1

69%
31%
<1%

129
183

42%
58%

78
137

36%
64%

51
45

53%
47%

312

100%

Vaccination Status Totals
Vaccinated
Unvaccinated
*Medicaid Vaccination
Vaccinated
Unvaccinated
Private Insurance Vaccination
Vaccinated
Unvaccinated
Total population size

*Statistical significance observed (p= .01)
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Table 2
Population Demographics 2013-2014 season
Number
2013-2014

Percent
2012-2013

Ages
Preschool (0-5 years)
School-Aged (6-12 years)
Adolescent (13-18 years)

153
298
174

24%
48%
28%

Gender
Male
Female

348
277

56%
44%

Insurance
Medicaid
Private Insurance
Self Pay

386
239
0

62%
38%
0%

262
363

42%
58%

171
215

44%
56%

Private Insurance Vaccination
Vaccinated
Unvaccinated

91
148

38%
62%

Total population size

625

100%

Vaccination Status Totals
Vaccinated
Unvaccinated
Medicaid Vaccination
Vaccinated
Unvaccinated
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Table 3
Significant differences between 2012-2013 and the 2013-2014 season

2012-2013

2013-2014

P value

Insurance Type
Medicaid
Private Insurance
Self Pay

215 (69%)
96 (31%)
1 (<1%)

386 (62%)
239 (38%)
0 (0%)

.03

Medicaid Vaccination
Vaccinated
Unvaccinated

78 (36%)
137 (64%)

171 (44%)
215 (56%)

.05

Private Insurance Vaccination
Vaccinated
Unvaccinated

51 (53%)
45 (47%)

91 (38%)
148 (62%)

.01

Total population size

312

625

Statistical Significance = (p < .05)

Chapter 5: Discussion
The literature clearly shows that children with asthma who contract influenza
have increased morbidity and mortality rates, and the economic burden of these diseases
are great. Expert consensus states that vaccination is the best way to prevent influenza.
Research has shown that this population is falling well below the national objective being
set forth by the AAP.
The literature review also reveals efforts are being made to increase these rates,
however, no one method has been identified that will deliver the most influential and
sustaining desired effect. If fact, the consensus of the literature reports this to be a
multifactorial issue that will take a multifactorial intervention to reach these objectives.
The evidenced-based intervention bundle identified by Minor’s (2013) research
was utilized for this study because of the multifaceted aspects of the bundle. The goal of
this researcher was not to find out which intervention made the change rather if the whole
of the bundle could offer a means to increase vaccination compliance among the children
with asthma at one local pediatric office. While the results of this study did fail to show
an overall significant improvement in the whole of the vaccination rates it did show
significant changes as it related to the type of insurance carried. Medicaid patients had a
significant increase in the number of children vaccinated (36% up to 44%), while the
private insurers had a significant decrease in the number of children vaccinated (53% to
38%).
Several factors may be attributable to these findings. This intervention created an
increased awareness, and led to diligence in influenza vaccination among these children.
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This urged the office to create a registry system specifically designed to track and log the
asthmatic children and their vaccination status. It is also important to note that Minor
(2013) excluded any asthmatic patient in this practice that did not visit the office during
the 2012-2013 influenza season. Whereas, this researcher included every asthmatic
patient in the practice regardless of whether a visit to the office occurred during the 20132014 influenza season. These may have been contributing factors into the increased
population size between the two respective influenza seasons, the indifference in the
whole of the results, and the differences observed with insurance types between the two
respective influenza seasons. This method of data collection was altered to ensure
comprehensive insight into the asthmatic children at this office.
Systems issues may have also contributed to some of the differences or lack of
difference observed between the two seasons. During the 2012-2013 influenza season
the office reported limited supplies for their Medicaid patients to utilize, wherein the
office reported no problems during the 2013-2014 season relating to the Medicaid
vaccination supply.
Another consideration that may have contributed to these results is that the office
had been made aware of the findings from Minor (2013) and may also have contributed
to increased diligence in vaccinating the Medicaid population. With this knowledge a
greater effort to increase this population may have occurred which could have potentially
and unwittingly also affected the private insurance group as well. Thus leading to the
significant decline in that groups vaccination rates. This research was not designed nor
intended to answer these questions.
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Other factors that could have affected vaccination status include the perceptions
regarding the threat of influenza. The 2011-2012 influenza season resulted in (total
deaths, not just asthmatic deaths) 35 pediatric deaths, while the 2012-2013 season
resulted in 171 pediatric deaths (CDC-‐	
  seasonal	
  influenza	
  (flu)-‐	
  weekly	
  report:	
  
influenza	
  summary	
  update,	
  2014).
No one factor can be attributed to these differences and indifferences. Increasing
vaccination rates among this population must first start with effort. Effort was made by
Minor (2013) to synthesize the data to offer this population the best available modality to
influence positive change. Effort was made by this pediatric office, as evidenced by their
adoption of this educational bundle and the creation of the asthma registry, which will
allow for better tracking of their asthmatic children.
When considering the significant changes as it related to the total pediatric
office population and insurance coverage verses the asthma population and insurance
coverage it is important to note that during both respective seasons the asthma patients
were predominantly Medicaid patients. This could be an important finding in that the
Medicaid patients presumably consist of lower income families and may live in situations
that expose these children to asthma risks (increased dust mites, pollution, pet dander,
older housing, and etc…) that may predispose them to the development of asthma in the
first place (ALA, 2014).
Future Implications
This study has begun to create a change at this office, and future research should
be continued to observe if, indeed, the educational intervention created by Minor (2013)
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will have effective and lasting effects on vaccination rates among asthmatic children at
this one pediatric office.
This research design will allow any potential future data analysis at this office to
include baseline comprehensive knowledge of the children with asthma. The design is
also easily reproducible. Additionally, future data analysis could include gathering data
on days missed from school related to flu symptoms and subsequent asthma
exacerbations to determine if increased influenza vaccination compliance will result in
fewer school absences and fewer asthma exacerbations during flu season. Medical record
numbers could be compared between two influenza seasons to determine those children
who receive the vaccination one year and then elect not to receive the vaccination the
next year. Follow up questions could then be obtained to help determine the why behind
choosing to decline the vaccination the subsequent year. The same could hold true for
those who do not get the vaccine the prior year and elect to the following year. Follow
up questions could be obtained from this group to help guide future interventions and to
help determine which interventions are most effective in influencing vaccination
compliance.
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